Product Overview

This product is a structurally complex pharmaceutical intermediate, chemically named 8-bromo-7-but-2-ynyl-3-methyl-1-(4-methylquinazoline-2-ylmethyl)-3,7-dihydropurine-2,6-dione, suitable for the synthesis and development of nucleoside analogues and novel antitumor drugs. This compound exhibits high reactivity and structural specificity, and is widely used in small-scale research, pilot-scale development, and industrial production stages. It is an important precursor for constructing novel purine derivatives, supporting diverse customer needs in new drug development, process optimization, and large-scale production.

Applications

• Raw materials for nucleoside analogue synthesis
• Development of intermediates for antitumor drugs
• Preparation of novel quinazoline derivatives
• Construction of drug molecular skeletons
• Optimization of process routes and scale-up production

Quality & Supply Capability

English Name: 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Properties: This product is a white to off-white solid with a stable purine ring structure and multiple functional groups, including bromine, alkynyl, methyl, and quinazolinyl groups. It exhibits good chemical stability and reactivity, making it suitable for various organic synthesis pathways. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Documentation Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust purity standards, impurity control schemes, packaging specifications, and delivery cycles according to customer needs, while providing complete quality documentation support to ensure that products meet GMP and R&D compliance requirements. We also provide technical support from laboratory research and development to industrial scale-up, helping customers to optimize processes, improve routes and transform projects, thereby enhancing overall R&D efficiency and production feasibility.

Why Choose Bioncan

Focused on pharmaceutical intermediates, with extensive experience in nucleoside and drug intermediate R&D. Full-scale supply capability to meet diverse needs from laboratory to commercial production. Provides complete quality control documentation to ensure product quality and compliance. Customized synthesis and process optimization can be performed according to specific customer requirements. Supporting scale-up technologies to help customers smoothly transition from R&D to production.

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 853029-57-9, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.